Results

Functional Expression Cloning of Ectodermin, a Maternal Determinant Promoting Ectoderm Development
We used an unbiased screening strategy to identify molecules involved in the specification of the embryonic ectoderm. To do this, we searched for genes that, once overexpressed in Xenopus embryos, could transform mesoderm cells into ectoderm precursors. The rationale of this approach relies on embryological observations indicating that, by the blastula stage, unidentified ectodermal determinants are located in the embryo's animal hemisphere and can direct the differentiation of ectoderm derivatives ( Figure 2B and Figure S2A ). dermin during Xenopus development by in situ hybridNext we tested to what extent Ectodermin is required ization and immunohistochemistry. Ectodermin RNA is for patterning of the whole embryo. Ecto-MO and conpresent in the animal pole of unfertilized eggs and trol-MO were injected in the prospective marginal zone throughout cleavage stages ( Figure 1D and data not of one-cell embryos and were analyzed by wholeshown). At the blastula stage, Ectodermin mRNA and mount in situ hybridization when embryos reached the protein are localized in the animal pole, extending, at gastrula stage. In Ecto-morphants, the mesoderm lower levels, up to the marginal zone ( Figures 1E, 1G , marker VegT was upregulated and expanded toward and 1H; see also Figure S1 ). At the onset of gastrulathe animal pole (compare Figures 2C and 2D ). Exprestion, Ectodermin RNA level has already dramatically sion of Mixer, which marks in the endoderm the border declined, but, intriguingly, it remains asymmetrically enwith the adjoining mesoderm, displayed an abnormal riched in the dorsal side of the early gastrula ( Figure Figure 3A) . We shortened axis, head reduction, and a ventral cyst of found that coinjection of Ecto mRNA inhibits in a dosean extensively folded epidermis ( Figures 1P and 1Q) Figure 3B , Ecto knockdown sensitized the response to Activin. This finding suggests that the expansion of specifically effective in reducing the level of endoge- tween Smad3 and Smad4. For BMP signaling, we moniments, we mapped the interaction domain with Smad4 in the linker region of Ectodermin ( Figure 4F ). Notably, tored transcription from the minimal Vent-2 promoter, whose activation relies on Smad1/Smad4 complexes.
the Ectodermin/Smad4 biochemical interaction is consistent with the biological effects of Ectodermin, being As shown in Figures 4A and 4B , raising the levels of Ectodermin in human cells inhibits the transcriptional that Smad4 is shared by the BMP and TGF-β signaling branches. response to TGF-β/BMP ligands on these reporters. These studies suggest that Ectodermin operates within Next we tested whether the antagonism between Ectodermin and TGF-β/BMP signals is mediated by its the TGF-β/BMP signaling cascades.
We investigated whether the biological antagonism specific interaction with Smad4. As shown in Figure 4G , expression of Smad4 rescues the activation of neural between Ectodermin and TGF-β signals reflected a physical interaction between Ectodermin and the Smads. markers by injected Ecto mRNA (lanes 2-4). Conversely, expression of Ectodermin counterbalances Indeed, coimmunoprecipitation experiments using epitope-tagged proteins from HEK293T cells showed that mesoderm expansion by increased Smad4 levels, as attained by mRNA injection in the marginal zone of the Ectodermin binds Smad4 but not other Smads ( Figure  4C ). To determine whether this interaction occurred at embryo ( Figure 4H . These results argue that the biological activity of Ectodermin as TGF-β antagonist primarily stems from mechanisms. One possibility that retained our attention the enzymatic activity of its RING finger rather than a concomitant rise of Smad4(R100T) to levels comparafrom other mechanisms, i.e., Smad4 sequestration. ble to those obtained by treatment with the proteasome The potential for Ectodermin to modulate the stability inhibitor MG132 ( Figure 5I ). This finding raises the interof Smad4 was tested in Xenopus cells. In the presence esting possibility that, during tumor progression, Ectoof coexpressed Ectodermin, the steady-state levels of dermin may cooperate with Smad4 mutations to attenSmad4 were severely decreased ( Figure 5B, lanes 5 uate TGF-β responsiveness in cancer cells. and 6), whereas Ectodermin had no effect on the steady-state levels of Smad2 or Smad3 ( Figure 5B,  lanes 1-4) . To investigate whether Ectodermin proEctodermin Antagonizes Nuclear motes Smad4 degradation, we analyzed the turnover Accumulation of Smad4 of overexpressed Smad4 by pulse-chase experiments We found that Ectodermin is an exclusive nuclear proin human HEK293T cells. Figure 5C shows that, altein ( Figure 1G and Figures S1E and S10) Figure 5D, lanes 1-3) , an effect reversed by treatment sumoylation, a treatment that antagonizes ubiquitinaof transfected cells with MG132, an inhibitor of the 26S tion, promotes Smad4 nuclear accumulation and metaproteasome ( Figure 5D, lanes 4-6) . Together, these data bolic stability (Lin et al.
, 2003). Given these precedents, indicate that Ectodermin enhances Smad4 degradation
we investigated whether Ectodermin regulates the via the ubiquitin-proteasome pathway.
nuclear versus cytoplasmic localization of Smad4. To Next we tested whether Ectodermin operates as a do so, we verified the localization of endogenous Smad4 ubiquitin ligase. As shown in Figure 5E 1-3) or 30 M MG132 (lanes 4-6) , and Smad4 steady-state levels were determined by Western blotting. Note that downregulation of Smad4 by hEcto (compare lanes 1-3) is inhibited in lanes 5 and 6. 
